Literature DB >> 3112609

Antifilamin, antivinculin, and antitropomyosin antibodies in myasthenia gravis.

T Yamamoto, T Sato, H Sugita.   

Abstract

Antifilamin, antivinculin, and antitropomyosin antibody activities were investigated in sera from 43 patients with myasthenia gravis (MG). Antifilamin and antivinculin antibody activities are significantly higher in MG patients compared with normal controls and patients with Duchenne muscular dystrophy (DMD), Parkinson's disease, and spinocerebellar degeneration. The antifilamin antibody was highly positive (100%) in ocular myasthenia. Antitropomyosin antibody activity was similar to that in DMD patients. No correlation was observed between these antibody activities and the antiacetylcholine receptor antibody titers, the duration of the disease, and thymic pathology.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112609     DOI: 10.1212/wnl.37.8.1329

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

Review 1.  The integrin-actin connection, an eternal love affair.

Authors:  Cord Brakebusch; Reinhard Fässler
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

2.  Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis.

Authors:  Alexandra Pevzner; Benedikt Schoser; Katja Peters; Nicoleta-Carmen Cosma; Andromachi Karakatsani; Berthold Schalke; Arthur Melms; Stephan Kröger
Journal:  J Neurol       Date:  2011-08-05       Impact factor: 4.849

3.  Linkage disequilibrium study of RFLPs detected at the human muscle nicotinic acetylcholine receptor subunit genes.

Authors:  E A Lobos; C H Rudnick; M S Watson; K E Isenberg
Journal:  Am J Hum Genet       Date:  1989-04       Impact factor: 11.025

4.  Beneficial effects of plasmapheresis before thymectomy on the outcome in myasthenia gravis.

Authors:  Takeshi Nagayasu; Takatomo Yamayoshi; Keitaro Matsumoto; Noboru Ide; Satoshi Hashizume; Masahito Nomura; Masashi Muraoka; Tsutomu Tagawa; Shinji Akamine; Tadayuki Oka
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-01

5.  Expression, crystallization and preliminary crystallographic data analysis of filamin A repeats 14-16.

Authors:  Adeleke Halilu Aguda; Amos Malle Sakwe; Lars Rask; Robert Charles Robinson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-03-12

6.  Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera.

Authors:  T Gordon; B Grove; J C Loftus; T O'Toole; R McMillan; J Lindstrom; M H Ginsberg
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 7.  Muscle autoantibodies in myasthenia gravis: beyond diagnosis?

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Expert Rev Clin Immunol       Date:  2012-07       Impact factor: 4.473

8.  Regulation of acetylcholine receptor alpha subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction.

Authors:  T Guyon; P Levasseur; F Truffault; C Cottin; C Gaud; S Berrih-Aknin
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 9.  [Molecular markers of various stages of nonsmall cell lung cancer development].

Authors:  I B Zborovskaia; A G Tatosian
Journal:  Mol Biol (Mosk)       Date:  2004 Mar-Apr

10.  Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays.

Authors:  Anne Becker; Nicole Ludwig; Andreas Keller; Björn Tackenberg; Christian Eienbröker; Wolfgang H Oertel; Klaus Fassbender; Eckart Meese; Klemens Ruprecht
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.